CIK 0001878313
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
MAIA Biotechnology, Inc.
Sign in to watch- Ticker
- MAIA
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 312-416-8592
- Business address
- 444 WEST LAKE STREET, SUITE 1700, CHICAGO, IL, 60606
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 1,200 shares at $2.47 ($2,964)
- 4 Open-market buy Director bought 3,000 shares at $2.63 ($7,890)
- 4 Open-market buy Chief Executive Officer bought 4,000 shares at $2.50 ($10,000)
- 4 Open-market buy Chief Financial Officer bought 4,400 shares at $2.25 ($9,900)
- 4 Open-market buy Director bought 8,500 shares at $2.25 ($19,125)
- 4 Open-market buy Director bought 48,000 shares at $2.25 ($108,000)
- 4 Open-market buy Director bought 133,300 shares at $2.25 ($299,925)
Page 8 of 13 · 248 filings